| (Values in U.S. Thousands) | Mar, 2026 | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 |
| Sales | 264,800 | 270,400 | 263,600 | 266,100 | 259,900 |
| Sales Growth | -2.07% | +2.58% | -0.94% | +2.39% | +0.66% |
| Net Income | 19,200 | -38,700 | 11,100 | 5,200 | 17,800 |
| Net Income Growth | +149.61% | -448.65% | +113.46% | -70.79% | +138.70% |
Enhabit Inc (EHAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas.
Fiscal Year End Date: 12/31